Interchange Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Buy |
3,452
+780
| +29% | +$64.7K | 0.07% | 226 |
|
|
2025
Q1 | $217K | Buy |
+2,672
| New | +$217K | 0.06% | 251 |
|
|
2024
Q4 | – | Sell |
-3,486
| Closed | -$344K | – | 273 |
|
|
2024
Q3 | $344K | Sell |
3,486
-5
| -0.1% | -$494 | 0.12% | 180 |
|
|
2024
Q2 | $324K | Buy |
+3,491
| New | +$324K | 0.12% | 180 |
|
|
2023
Q2 | – | Sell |
-1,272
| Closed | -$96.9K | – | 220 |
|
|
2023
Q1 | $96.9K | Buy |
+1,272
| New | +$96.9K | 0.05% | 206 |
|
|
2021
Q1 | – | Sell |
-325
| Closed | -$45K | – | 1111 |
|
|
2020
Q4 | $45K | Buy |
+325
| New | +$45K | 0.02% | 428 |
|